Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology
Clinical Trials: Myocardial Ischemia
A listing of clinical trials currently looking for volunteers to enroll in Myocardial Ischemia studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Trinity Hospital
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Birmingham : Cardiology, PC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Birmingham : University of Alabama at Birmingham
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Huntsville : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Huntsville : Heart Center Research, LLC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
View More »
Huntsville : Heart Center Research, LLC
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Mobile : Spring Hill Hospital
Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography
Alaska
Anchorage : Alaska Heart Institute
PRE-DETERMINE Cohort Study
Little Rock : Arkansas Heart Hospital
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Arizona
Gilbert : Mercy Gilbert Medical Center
An Observational Study of Cholesterol in Coronary Arteries
Phoenix : Cardiovascular Consultants
PRE-DETERMINE Cohort Study
Scottsdale : Scottsdale Imaging
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Scottsdale : Scottsdale Healthcare
An Observational Study of Cholesterol in Coronary Arteries
Scottsdale : Scottsdale Healthcare Shea
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
View More »
Tucson : University of Arizona
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Tucson : University of Arizona
PRE-DETERMINE Cohort Study
Arkansas
Little Rock : Heart Clinic Arkansas
PRE-DETERMINE Cohort Study
Little Rock : Arkansas Heart Hospital
The OMEGA Clinical Trial
Little Rock : Cardiology and Medicine Clinic
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
California
Beverly Hills : West Side Medical Associates of Los Angeles
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Glendale : Glendale Memorial Hospital and Health Center
PRE-DETERMINE Cohort Study
Imperial : Imperial Cardiac Center
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
La Jolla : Scripps Clinic Updated
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
La Jolla : University of California San Diego
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
View More »
La Jolla : Scripps Clinic
Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)
Los Angeles : Cedars-Sinai Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Los Angeles : UCLA
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Los Angeles : USC PET Imaging Science Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Los Angeles : VA West Los Angeles Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Los Angeles : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Los Angeles : University of California, Los Angeles Medical Center
An Observational Study of Cholesterol in Coronary Arteries
Los Angeles : Good Samaritan Hospital
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Los Angeles : University of California Medical Center
PRE-DETERMINE Cohort Study
Merced : Merced Heart Associates
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Mission Viejo :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Mission Viejo : Mission Internal Medical Group
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Moreno Valley : Spectrum Clinical Research Institute, Inc
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Moreno Valley : Spectrum Clinical Research Institute, Inc
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Newport Beach : Hoag Memorial Hospital Presbyterian and Radin Inc.
PRE-DETERMINE Cohort Study
Orange : University of California Irvine Medical Center
An Observational Study of Cholesterol in Coronary Arteries
Palm Springs : Eisenhower Medical Center
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Palo Alto : Veterans Affairs Palo Alto Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Pasadena : Novartis Investigative Site
Efficacy of LCQ908 on Cardiovascular Risk
Pasadena : Huntington Hospital
PRE-DETERMINE Cohort Study
Pleasant Hill : Cardiovascualr Consultants Medical Group
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Rancho Mirage : Desert Cardiology Center
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Sacramento : Northern California PET Imaging Center-Palo Alto
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Sacramento : Sacramento Heart and Vascular Reseach Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Sacramento : Sutter Memorial Hospital
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Sacramento : Mercy Heart and Vascular Institue
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Sacramento : Catholic Healthcare West (Mercy General Hospital) and Regional Cardiology Associates
PRE-DETERMINE Cohort Study
Sacramento : Sutter Memorial Hospital
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Sacramento : Sacramento Heart and Vascular Medical Associates
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
San Diego : VA San Diego Healthcare System
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
San Diego : Naval Medical Center
Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique
San Diego : University of California, San Diego Updated
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
San Francisco : San Francisco Veterans Affairs Medical Center
An Observational Study of Cholesterol in Coronary Arteries
San Francisco : San Francisco Veterans Affairs Medical Center
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Santa Clara : Abbott Vascular
EXCEL Clinical Trial
Santa Clara : Abbott Vascular
EXCEL Clinical Trial (Universal Registry)
Santa Clara : Abbott Vascular
EXPERT CTO: Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions
Torrance : Harbor UCLA Medical Center
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
Walnut Creek : John Muir Medical Center Concord Campus
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Colorado
Aurora :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Colorado Springs : Pikes Peak Cardiology
PRE-DETERMINE Cohort Study
Denver : Cardiovascular Associates, P.C.
PRE-DETERMINE Cohort Study
Connecticut
Bridgeport : Connecticut Clinical Research, LLC
Evaluation of Microvolt T-Wave Alternans(MTWA) Testing for the Detection of Active Ischemia
Danbury : Danbury Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Hartford : Hartford Hospital
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Hartford : Hartford Hospital
The OMEGA Clinical Trial
New Haven : Yale University
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
View More »
New Haven : Yale New Haven Hospital
Detecting Heart Disease Using First Pass Imaging With Gated SPECT Perfusion
Delaware
Newark : Alfieri Cardiology
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Newark : Christiana Care Health System
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Newark : Alfieri Cardiology
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Florida
Atlantis : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Atlantis : Cardiology Associates of Palm Beach - Atlantis
PRE-DETERMINE Cohort Study
Boyton Beach : Zasa Clinical Research
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Brandon : Bay Area Cardiology Associates, P.A.
PRE-DETERMINE Cohort Study
Clearwater : Coastal Cardiology Consultants dba The Heart & Vascular Institute of Florida
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
View More »
Daytona Beach : Florida Hospital Memorial
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Daytona Beach : Cardiology Research Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Fort Lauderdale : Broward General Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Gainesville : University of Florida, Gainesville
An Observational Study of Cholesterol in Coronary Arteries
Hollywood : Research Site
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
Hollywood : HealthwoRx
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Jacksonville : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Jacksonville : Mayo Clinic Research Unit
Exercise Stress Testing on Peripheral Gene Expression Using CORUS™ CAD Diagnostic Test
Jacksonville : Univ. of Florida College Medicine
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Jacksonville : Shands Jacksonville Medical Center
PRE-DETERMINE Cohort Study
Jacksonville : Jacksonville Heart Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Jacksonville : University of Florida
Regadenoson to Achieve Maximal Hyperemia for Fractional Flow Reserve in the Catheterization Lab
Jacksonville : St. Luke's Cardiology Associates
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Jacksonville : Jacksonville Heart Center
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Kissimmee : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Miami : Cardiovascular Research Center of South Florida
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
Miami : Clinical Pharmacology Unit of Miami
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Miami : Cardiovascular Research Center of South Florida
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Miami Beach : Mount Sinai Medical Center
PRE-DETERMINE Cohort Study
Ocala : Munroe Regional Medical Center
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Orlando : Florida Hospital/Cardiovascular Institute (Florida Heart Group)
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Orlando : Florida Hospital Updated
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Orlando : Florida Hospital
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Orlando : Orlando Regional
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Orlando : Florida Hospital Cardiovascular Research Institute
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Orlando : Orlando Regional Healthcare System
PRE-DETERMINE Cohort Study
Orlando : Research One
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Orlando : Florida Hospital
The OMEGA Clinical Trial
Panama City : Cardiovascular Institute of Northwest Florida
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Pensacola :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Pensacola : Cardiology Consultants of Northwest Florida
PRE-DETERMINE Cohort Study
Port Orange : Progressive Medical Research
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Sarasota : Sarasota Memorial Hospital
The OMEGA Clinical Trial
St. Petersburg : The Heart and Vascular Institute of Florida
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Tallahassee : Tallahassee Research Institute
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Tampa : Memorial Hospital of Tampa
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
West Palm Beach : Cardiology Associates of Palm Beach - West Palm Beach
PRE-DETERMINE Cohort Study
Winter Haven : Winter Haven
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Winter Haven : Clinical Research of Central Florida
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Winter Park :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Georgia
Atlanta : Piedmont Hospital
An Observational Study of Cholesterol in Coronary Arteries
Atlanta : Saint Joseph's Health System, Inc.
LifeVest Post-CABG Registry
Atlanta : Emory University Hospital Midtown
Management of New-Onset Postoperative Atrial Fibrillation
Atlanta : Piedmont Hospital (Fuqua Heart Center)
PRE-DETERMINE Cohort Study
Atlanta : Emory University
PRE-DETERMINE Cohort Study
View More »
Atlanta : Emory University Hospital
RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery
Atlanta : Emory University Hospital
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Augusta : Masters of Clinical Research, Inc.
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Columbus : Columbus Cardiology Associates, PC
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Cumming : Atlanta Heart Specialist, LLC
Ranolazine, Ethnicity and the Metabolic Syndrome
Gainesville : Northeast Georgia Heart Center, PC
PRE-DETERMINE Cohort Study
Lawrenceville : Cardiovascular Group, P.C.
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Macon : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Savannah : South Coast Imaging Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Suwanee : John's Creek Primary Care
Primary Care Providers Use of a Gene Expression Test in Coronary Artery Disease Diagnosis
Tucker : Atlanta Heart Specialists, LLC
Ranolazine, Ethnicity and the Metabolic Syndrome
Illinois
Aurora : Fox Valley Clinical Research Center, LLC
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Chicago : Northwestern University
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
Chicago : Northwestern University
Half-Dose Radiopharmaceutical in Wide Beam Reconstruction
Chicago : Northwestern University Feinberg School of Medicine
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Chicago : Northwestern University
PRE-DETERMINE Cohort Study
View More »
Evanston : Evanston Northwestern Healthcare - Evanston Hospital
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Jerseyville : Gateway Cardiology, PC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Lombard : Midwest Heart Foundation
PRE-DETERMINE Cohort Study
Springfield : Southern Illinois University-Memorial Medical Center
The OMEGA Clinical Trial
Indiana
Fort Wayne : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Fort Wayne : Lutheran Hospitalof Indiana and Northern Indiana Research Alliance of the Heart Center Medical Group
PRE-DETERMINE Cohort Study
Indianapolis :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Indianapolis : The Care Group
PRE-DETERMINE Cohort Study
Indianapolis : St. Vincent's Hospital
The OMEGA Clinical Trial
View More »
Munster : Community Hospital
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Valparaiso : Northwest Indiana Cardiovascular Physicians
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Iowa
West De Moines : Iowa Heart Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
West Des Moines : Iowa Heart Medical Center
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
West Des Moines : Iowa Heart Center
PRE-DETERMINE Cohort Study
Kansas
Kansas City :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Kansas City : The University of Kansas
PRE-DETERMINE Cohort Study
Overland Park : Midwest Cardiology Associates, P.C.
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
Shawnee Mission : Shawnee Mission Hospital
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Kentucky
Ashland : Kentucky Heart Institute
PRE-DETERMINE Cohort Study
Elizabethtown : Central Cardiology Associates
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Lexington : Baptist Healthcare System Inc. (Central Baptist Hospital)
PRE-DETERMINE Cohort Study
Lexington : Saint Joseph Cardiology Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Lexington : St. Joseph Hospital
The OMEGA Clinical Trial
View More »
Owensboro : Research Integrity, LLC
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Owensboro : Research Integrity, LLC
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Louisiana
Covington : Louisiana Heart Center
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Hammond : Louisiana Heart Center
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Mandeville : Clinical Trials Management, LLC
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
New Orleans : Ochsner Clinic Foundation
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
New Orleans : Ochsner Medical Center
Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)
View More »
Shreveport : Biomedical Research Foundation
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Slidell : Louisiana Heart Center
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Maine
Auburn : Maine Research Associates
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Auburn : Maine Research Associates
PRE-DETERMINE Cohort Study
Bangor : Northeast Cardiology Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Portland : Maine Medical Center
The OMEGA Clinical Trial
Maryland
Baltimore : Johns Hopkins School of Medicine
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
Baltimore : Sinai Center for Thrombosis Research
Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis
Baltimore : University of Maryland Medical Center
PRE-DETERMINE Cohort Study
Baltimore : John Hopkins University
PRE-DETERMINE Cohort Study
Baltimore : Union Memorial Hospital
The OMEGA Clinical Trial
View More »
Bethesda : National Heart Lung and Blood Institute (NHLBI)
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
Bethesda : Cardiovascular and Pulmonary Branch (CPB) of NIH
Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease
Salisbury : Delmarva Heart Research Foundation, Inc
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Takoma Park : Washington Adventist Hospital
An Observational Study of Cholesterol in Coronary Arteries
Towson : Research Site
A Pharmacodynamic Study With Ticagrelor in African American Patients
Towson : Research Site
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
Massachusetts
Boston : Brigham and Women's Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Boston : Mass General Hospital (MGH)
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Boston : Brigham and Women's Hospital
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
Boston : Massachusetts General Hospital
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
Boston :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
View More »
Boston : Beth Israel Deaconess Medical Center
An Observational Study of Cholesterol in Coronary Arteries
Boston : Massachusetts General Hospital
An Observational Study of Cholesterol in Coronary Arteries
Boston : Beth Israel Deaconess Medical Center
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
Boston : Brigham and Women Hospital
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
Boston : Massachusetts General Hospital
Evaluation of a Combined Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Catheter for Detection of Lipid Rich Plaque
Boston : Caritas St. Elizabeth's Medical Center
PRE-DETERMINE Cohort Study
Boston : Brigham and Women's Hospital
PRE-DETERMINE Cohort Study
Boston : Massachusetts General Hospital
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Boston : Massachusetts General Hospital
Subclinical Atherosclerosis in HIV-infected Patients
Boston : Massachusetts General Hospital
The Massachusetts General Hospital Optical Coherence Tomography Registry
Brighton : St. Elizabeth's Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Hyannis : Cape Cod Research Institute
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Pittsfield : Berkshire Medical Center
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
Michigan
Alpena : Endeavor Medical Research, PLC
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Ann Arbor : University of Michigan Health System
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Ann Arbor :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Ann Arbor : University of Michigan Medical School
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Ann Arbor : University of Michigan Medical Center
PRE-DETERMINE Cohort Study
View More »
Dearborn : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Detroit : Henry Ford Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Detroit : Harper University Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Detroit : Henry Ford Health System
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
Detroit : Detroit Medical Center
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Detroit : St. John's Hospital
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Detroit : Henry Ford System
PRE-DETERMINE Cohort Study
East Lansing : Michigan State University
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Grand Rapids : St. Mary's Healthcare
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Grand Rapids : Spectrum Health Hospitals
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Kalamazoo : Advanced Cardiac Healthcare (Bronson Methodist Hospital)
PRE-DETERMINE Cohort Study
Mount Clemens : McLaren Macomb
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Mt. Clemens : Mount Clemens Regional Medical Center
PRE-DETERMINE Cohort Study
Petoskey : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Pontiac : St. Joseph Mercy
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Royal Oak : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Royal Oak : William Beaumont Hospital
An Observational Study of Cholesterol in Coronary Arteries
Royal Oak : William Beaumont Hospital
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Royal Oak : William Beaumont Hospital-Royal Oak
Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique
Royal Oak : William Beaumont Hospital
PRE-DETERMINE Cohort Study
Saginaw :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Saginaw : Michigan Cardiovascular Institute Updated
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
St. Joseph : Lakeland
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Troy : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Troy : William Beaumont Hospital-Troy
Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique
Minnesota
Coon Rapids : Mercy Hospital
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Duluth : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Duluth : Essentia Health
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Duluth : St. Mary's Duluth Clinic Regional Heart Center
The OMEGA Clinical Trial
Minneapolis : Minneapolis Heart Institute at Abbott Northwestern Hospital
Alternative in Beta Blocker Intolerance: The ABBI Trial
View More »
Minneapolis : Minneapolis Heart Institute/ Abbott Northwestern
Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique
Minneapolis : Minneapolis Heart Institute Foundation
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Minneapolis : Minneapolis Heart Institute Updated
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Minneapolis : Minneapolis Heart Institute Foundation
PRE-DETERMINE Cohort Study
Minneapolis : Metropolitan Cardiology Consultants (MCC) / Allina Health System (Mercy & Unity Hospitals)
PRE-DETERMINE Cohort Study
Minneapolis : Abbott Northwestern Hospital
The OMEGA Clinical Trial
Minneapolis : Abbott Northwestern Hospital
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Rochester : Mayo Clinic
An Observational Study of Cholesterol in Coronary Arteries
Rochester : Mayo Clinic
Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
Rochester : Mayo Clinic
Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III
Rochester : Mayo Clinic
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Saint Cloud : Saint Cloud Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Saint Paul : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
St. Cloud :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Mississippi
Tupelo : Cardiology Associates of North Mississippi
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Missouri
Columbia : Missouri Cardiovascular Specialists, LLP
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Columbia : University of Missouri Health Care
PRE-DETERMINE Cohort Study
Joplin : Freeman West Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Kansas City : Cardiovascular Imaging Technologies (CVIT)
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Kansas City : Saint Luke's Cardiovascular Consultants
Effectiveness Study of Single Photon Emission Computed Tomography (SPECT) Versus Positron Emission Tomography (PET) Myocardial Perfusion Imaging
View More »
Kansas City : Cardiovascular Imaging Technologies
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Saint Louis : Gateway Cardiology, PC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Springfield : Saint John's Regional Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
St. Louis : Washington University School of Medicine
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
St. Louis :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
St. Louis : Saint Louis University Hospital
An Observational Study of Cholesterol in Coronary Arteries
St. Louis : Missouri Baptist Medical Center
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
St. Louis : St. Louis University
Regadenoson to Achieve Maximal Hyperemia for Fractional Flow Reserve in the Catheterization Lab
Montana
Nebraska
Nevada
Henderson : Cardiovascular Consultants of Nevada
Safety of Amiodarone and Ranolazine Together in Patients With Angina
Las Vegas : Cardiovascular Consultants of Nevada
Safety of Amiodarone and Ranolazine Together in Patients With Angina
New Jersey
Camden : Cooper University Hospital
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Cherry Hill : Our Lady of Lourdes Medical Center
The OMEGA Clinical Trial
Edgewater : Cross Country Cardiology
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Morristown : Morristown Memorial Hospital
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Newark : University Medical and Denistry of New Jersey
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
View More »
Ridgewood : The Valley Hospital
PRE-DETERMINE Cohort Study
Summit :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Teaneck : Holy Name Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
New Mexico
New York
Albany : Capital Cardiology Associates
Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac Computed Tomography (CT) Scanning
Albany : Albany Associates Cardiology
PRE-DETERMINE Cohort Study
Bronx : Montefiore Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Brooklyn : New York Methodist Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Buffalo : Buffalo Heart Group
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
View More »
Kingston : Mid-Valley Cardiology
PRE-DETERMINE Cohort Study
Manhasset : North Shore University Hospital, NY
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Mineola : Winthrop-University Hospital
PRE-DETERMINE Cohort Study
N. Massapequa :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
New Hyde Park : Long Island Jewish Medical Center
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
New York : Columbia University Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
New York : Mount Sinai Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
New York : Columbia Universtiy Medical Center
An Observational Study of Cholesterol in Coronary Arteries
New York : Mount Sinai School of Medicine
An Observational Study of Cholesterol in Coronary Arteries
New York : NYU Langone Medical Center
Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique
New York : Lenox Hill
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
New York : Novartis Investigative Site
Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
New York : Columbia University Health Center
PRE-DETERMINE Cohort Study
New York : St. Luke's - Roosevelt Hospital Center
PRE-DETERMINE Cohort Study
New York : New York Presbyterian Hospital (Weill Medical College)
PRE-DETERMINE Cohort Study
New York : Columbia University Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
New York : Columbia University Medical Center
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
New York : Mount Sinai School of Medicine
The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery
New York City : Columbia University Medical Center
Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety & Effectiveness of the Tryton Side Branch Stent Used With DES in Treatment of de Novo Bifurcation Lesions in the Main Branch & Side Branch in Native Coronaries
Poughkeepsie : Hudson Valley Heart Center
Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac Computed Tomography (CT) Scanning
Poughkeepsie : Hudson Valley Heart Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Roslyn : St. Francis Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Roslyn : St. Francis Hospital
PRE-DETERMINE Cohort Study
Stony Brook : Stony Brook University Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Syracuse : St. Joseph's Hospital Health Center, NY
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Utica : Central New York Cardiology
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Williamsville : Buffalo Cardiology and Pulmonary Associates, PC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
North Carolina
Asheville : Asheville Cardiology Associates
PRE-DETERMINE Cohort Study
Charlotte : Carolina Family Healthcare
Primary Care Providers Use of a Gene Expression Test in Coronary Artery Disease Diagnosis
Charlotte : Mid Carolina Cardiology
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Durham : Duke University Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Durham : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
View More »
Durham : Veterans Affairs Medical Center, Duke University Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Durham : Duke University Medical Center
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Greensboro : LeBauer Cardiovascular Research Foundation and Moses H. Cone Memorial Hospital
PRE-DETERMINE Cohort Study
High Point : Carolina Cardiology Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Raleigh : Wake Heart Research
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Raleigh : Wake Medical Center
The OMEGA Clinical Trial
Ohio
Cincinnati : University of Cincinnati
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Cincinnati : The Lindner Clinical Trial Center Updated
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Cincinnati : Medpace Clinical Pharmacology Unit
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Cincinnati : Good Samaritan Hospital
The OMEGA Clinical Trial
Cincinnati : The Carl & Edyth Lindner Center for Research and Education at The Christ Hospital
The OMEGA Clinical Trial
View More »
Cleveland : Cleveland Clinic Foundation
Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique
Cleveland : Cleveland Clinic Foundation
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Cleveland : The Cleveland Clinic Foundation
PRE-DETERMINE Cohort Study
Cleveland : The MetroHealth System
PRE-DETERMINE Cohort Study
Cleveland : University Hospitals of Cleveland
PRE-DETERMINE Cohort Study
Columbus : OhioHealth Research Institute
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Columbus : The Ohio State University
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Columbus : Ohio State University Medical Center
The OMEGA Clinical Trial
Columbus : Riverside Methodist Hospital
The OMEGA Clinical Trial
Dayton : Good Samaritan Dayton
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Elyria : North Ohio Research, Ltd.
PRE-DETERMINE Cohort Study
Kettering : Kettering Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Kettering : Southwest Cardiology, Inc
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Toledo : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Toledo : Northwest Ohio Cardiology Consultants/The Toledo Hospital
PRE-DETERMINE Cohort Study
Toledo : Mercy St. Vincent Medical Center
The OMEGA Clinical Trial
Toledo : The Toledo Hospital
The OMEGA Clinical Trial
Zanesville : Cardiology Associates of Southeast Ohio, Inc.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Oklahoma
Oregon
Portland : Oregon Health and Science University
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
Portland : Providence Heart & Vascular Institute
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Pennsylvania
Abington : Abington Memorial Hospital
PRE-DETERMINE Cohort Study
Allentown : Lehigh Valley Hospital and Health Network
PRE-DETERMINE Cohort Study
Beaver : The Heart and Vascular Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Camp Hill : Heritage Cardiology
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Doylestown : Central Bucks Cardiology
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
View More »
Erie : Saint Vincent Health Care Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Harrisburg : Pinnacle Health Cardiovascular Institute/ Associated Cardiologists
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Harrisburg : Pinnacle Heart & Vascular Institute
An Observational Study of Cholesterol in Coronary Arteries
Harrisburg : Pinnacle Health Cardiovascular Insititute
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Lancaster :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Philadelphia : Jefferson Heart Institute
Extracellular Matrix Marker of Arrhythmia Risk (EMMA)
Philidelphia : Presbyterian University of Pennsylvania Medical Center
The OMEGA Clinical Trial
Pittsburg : Alleghany General Hospital
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Pittsburgh : Presbyterian University Hospital
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Pittsburgh : UPMC Presbyterian Hospital Updated
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Pittsburgh : University of Pittsburgh Medical Center
Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Pittsburgh : University of Pittsburgh Medical Center
PITT PCI Xience Registry
Pittsburgh : Allegheny-Singer Research Institute (Allegheny General Hospital)
PRE-DETERMINE Cohort Study
Pittsburgh : University of Pittsburgh Medical Center
PRE-DETERMINE Cohort Study
Pittsburgh : Veterans Administration Medical Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Pittsburgh : University of Pittsburgh Medical Center Cardiovascular Institute
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Wormleysburg : Pinnacle Health System
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Wyomissing : Berks Cardiologists, Ltd.
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Yardley : St. Mary Medical Center
The OMEGA Clinical Trial
York : York Hospital /Wellspan Health
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Rhode Island
Providence : Rhode Island Hospital
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
South Carolina
Anderson : AnMed Health
PRE-DETERMINE Cohort Study
Anderson : AnMed Health
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Charleston : Medical University of South Carolina
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Charleston : Medical University of South Carolina Hospital
An Observational Study of Cholesterol in Coronary Arteries
Charleston : Medical University of South Carolina Hospital
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
View More »
Charleston : Medical University of South Carolina
Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique
Charlston :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
South Dakota
Rapid City :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Rapid City : Black Hills Cardiovascular Research
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Rapid City : Black Hills Cardiovascular Research
PRE-DETERMINE Cohort Study
Rapid City : Black Hills Cardiovascular Cardiology Associates P.C.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Tennessee
Jackson : Research Associates of Jackson
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Jackson : Kore Cardiovascular Research
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Jackson : Heart and Vascular Center of West TN
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Johnson City : Mountain States Health Alliance Corporate Department of Research
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Kingsport : Wellmont CVA Heart Institute
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
View More »
Knoxville : Cardiovascular Research of Knoxville
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Knoxville : Center for Biomedical Research
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Knoxville : Cardiovasular Research of Knoxville
PRE-DETERMINE Cohort Study
Memphis : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Memphis : Baptist Memorial Hospital-DeSoto
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Memphis : Memphis Heart Clinic
PRE-DETERMINE Cohort Study
Nashville : Vanderbilt University Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Nashville : St. Thomas Research Institute
PRE-DETERMINE Cohort Study
Nashville : Vanderbilt University
PRE-DETERMINE Cohort Study
Nashville : Centennial Heart Cardiovascular Consultants, LLC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Texas
Amarillo : Cardiology Center of Amarillo, LLP
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Dallas : Dallas VA Medical Center
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Dallas : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Dallas : Veterans Affairs, North Texas Health Care Systems
An Observational Study of Cholesterol in Coronary Arteries
Dallas : Veterans Affairs North Texas Health Care Systems
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
View More »
Dallas : North Texas Healthcare System, Dept. of Veteran's Affairs
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Dallas : Medical City Hospital
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
Houston : The Methodist Hospital Updated
Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease
Houston : St. Luke's
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Houston : West Houston Area Clinical Trial Consultants
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
Houston : Methodist Hospital Research Institute
PRE-DETERMINE Cohort Study
Houston : St. Luke's Episcopal Hospital
PRE-DETERMINE Cohort Study
Houston : East Texas Cardiology PA
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Houston : Med-Tech Research
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Humble : Humble Cardiology Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Humble : Humble Cardiology Associates
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Katy : Katy Cardiology
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Mission : Gamma Medical Research Inc.
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Plano : The Heart Hospital Baylor Plano
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
Temple : Scott & White Memorial Hospital
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Temple : Scott & White Memorial Hospital
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Tomball : Northwest Houston Heart Center
Evaluation of Microvolt T-Wave Alternans(MTWA) Testing for the Detection of Active Ischemia
Victoria : Victoria Heart and Vascular Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Utah
Layton : Davis Hospital
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Salt Lake City : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Salt Lake City : St. Marks Hospital
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Salt Lake City : Intermountain Healthcare
Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64
Vermont
Virginia
Charlottesville : University of Virginia
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Charlottesville : University of Virginia
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus
Charlottesville : University of Virgina Health System
PRE-DETERMINE Cohort Study
Charlottesville : University of Virginia Health System
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Falls Church : Inova Heart and Vascular Institute
CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM
View More »
Norfolk : Sentara Cardiovascular Research Institute
PRE-DETERMINE Cohort Study
Norfolk : Sentara Cardiovascular Research Institute
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Richmond : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Roanoke : Carilion Cardiology Clinic
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Roanoke : Roanoke Heart Institute
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Virginia Beach : Cardiovascular Associates Virginia Beach
PRE-DETERMINE Cohort Study
Washington
Seattle : Swedish Medical Center
An Observational Study of Cholesterol in Coronary Arteries
Seattle : Swedish Medical Center Updated
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
West Virginia
Wisconsin
Wausau : Wausau Heart & Lung Surgeons
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Argentina
Buenos Aires :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Buenos Aires : Hospital Italiano de Buenos Aires
Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease
Córdoba :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Corrientes :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Australia
Adelaide : Royal Adelaide Hospital
ABSORB EXTEND Clinical Investigation
Adelaide : Royal Adelaide Hospital
ABSORB PHYSIOLOGY Clinical Investigation
Auchenflower : Wesley Hospital
ABSORB EXTEND Clinical Investigation
Heidelberg : Austin Health
ABSORB PHYSIOLOGY Clinical Investigation
Melbourne : St. Vincent's Hospital
ABSORB EXTEND Clinical Investigation
View More »
Melbourne : Monash Medical Centre
ABSORB PHYSIOLOGY Clinical Investigation
Randwick : Eastern Heart Clinic, The Prince of Wales Hospital
ABSORB EXTEND Clinical Investigation
Victoria : Monash Medical Center
ABSORB EXTEND Clinical Investigation
Austria
Graz : Landeskrankenhaus Graz West
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Linz : Allgemeines Krankenhaus der Stadt Linz
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Vienna : Krankenhaus Hietzing
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Belgium
Aalst : Onze-Lieve VrouweZiekenhuis
ABSORB EXTEND Clinical Investigation
Aalst : OLV Ziekenhuis Aalst
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT
Antwerp : AZ Middelheim
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT
Antwerpen : ZNA Middelheim
Safety and Effectiveness of the Coronary Momo Stent
Antwerpen, Linderreef 1 : Academic Hospital Middelheim
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
View More »
Bonheiden : Imelda vzw
Safety and Effectiveness of the Coronary Momo Stent
Bonheiden : Imelda Ziekenhuis
The OMEGA Clinical Trial
Brugge : AZ Sint Jan
Safety and Effectiveness of the Coronary Momo Stent
Brussel : UZ Brussel
Safety and Effectiveness of the Coronary Momo Stent
Brussels : Abbott Vascular International BVBA
ABSORB II Randomized Controlled Trial
Brussels :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Charleroi :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Edegem :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Edegem :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Edegem : Universitair Ziekenhuis Antwerpen
The OMEGA Clinical Trial
Genk :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Genk : Ziekenhuis Oost-Limburg
Safety and Effectiveness of the Coronary Momo Stent
Gent : AZ Maria Middelares
Safety and Effectiveness of the Coronary Momo Stent
Gent : Universitair Ziekenhuis Gent
The OMEGA Clinical Trial
Haine St. Paul :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Hasselt :
Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
Hasselt : Virga Jesse Ziekenhuis
The OMEGA Clinical Trial
Liege :
Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
Roeselare :
Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
Brazil
Barbacena : Hospital Ibiapaba de Barbacena
A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus
Belém : Centro Integrado de Medicina Intervencionista
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Blumenau : Hospital Santa Isabel
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Brasília : Hospital Anchieta
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Catanduva : Cardiologia Catanduva
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
View More »
João Pessoa : Cardiocenter
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Limeira : Santa Casa de Limeira
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Linhares : UNICOR
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Marília : Santa Casa de Marília
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Palmas : INTERVECENTER Serviços Cardiovasculares
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Piracicaba : INCORPI - Hosp. Fornecedores de Cana
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Piracicaba : EMCOR Emergências do Coração
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Porto Alegre : Hospital Mãe de Deus
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Porto Alegre : Hospital São Lucas da PUC
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Porto Alegre : Fundação Universitária de Cardiologia
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Recife : Procape
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Recife : Hospital Agamenon Magalhães
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Ribeirão Preto : Hospital das Clínicas de Ribeirão Preto
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
São Carlos : Santa Casa de São Carlos
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Sao Paulo : Albert Einstein Hospital
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
Sao Paulo : INCOR Heart Institute University-Sao Paulo
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
São Paulo : Hospital Santa Marcelina
A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus
São Paulo : Instituto de Assistêcia Médica ao Servidor Publico Estadual
A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus
São Paulo : Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP
A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus
São Paulo : Hospital Santa Marcelina
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
São Paulo : Instituto de Assistencia Médica ao Sevidor Público Estadual- IAMSPE
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
São Paulo : Hospital Bandeirantes
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
São Paulo : Hospital Beneficência Portuguesa
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
São Paulo : Instituto Dante Pazzanese de Cardiologia
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Uberaba : Universidade Federal do Triangulo Mineiro
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Uberlândia : Instituto do Coração do Triângulo Mineiro
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Canada
Burlington : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Cambridge : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Chicoutimi :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Coquitlam : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Edmonton : University of Alberta and Mazankowski Alberta Heart Institute
Autologous Cell Therapy for Ischemic Heart Failure
View More »
Granby : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Halifax : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Hamilton : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Hamilton : Hamilton Health Sciences, General Site
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Kelowna : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Lachine : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
London : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Longueuil : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Mississauga : KMH Cardiology and Diagnostic Centres
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Moncton : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Montreal : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Montreal : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Montreal :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Montreal : Montreal Heart Institute
Autologous Cell Therapy for Ischemic Heart Failure
Montreal : Chum Hotel Dieu
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Montreal : Montreal Heart Institute
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Montréal : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Oakville : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Oshawa : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Ottawa : University of Ottawa Heart Institute
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Ottawa : University of Ottawa Heart Institute
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Quebec City : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Saint John : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Saint John : New Brunswick Heart Centre
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Saint John's : Topsail Road Medical Clinic
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Sainte-Foy :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Sarnia : London Road Diagnostic Clinic and Medical Centre
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Scarborough : Scarborough Cardiology Research Associates
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Sudbury : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Sudbury : Dr. Roger Labonté Professional Medicine Corp.
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Toronto : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Toronto : Updated
A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
Toronto : Dr Anil K Gupta Medicine Professional Corp.
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Trois-rivières : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Val D'or : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Vancouver : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Vancouver : St. Paul's Hospital
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Vancouver : Vancouver General Hospital
PRE-DETERMINE Cohort Study
China
Anshan : The Central Hospital of Anshan
Acarbose Cardiovascular Evaluation Trial
Baotou : Baotou Central Hospital
Acarbose Cardiovascular Evaluation Trial
Baotou : The First Affiliated Hospital of Baotou Medical College
Acarbose Cardiovascular Evaluation Trial
Beijing : Cardiovascular Institute and Fu Wai Hospital
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Beijing : Peking Union Medical College Hospital
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
View More »
Beijing : Peking University First Hospital
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Beijing : The Chinese People's Liberation Army General Hospital
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Beijing : Anzhen Hospital of The Capital University of Medical Sciences 2nd.
Acarbose Cardiovascular Evaluation Trial
Beijing : Beijing Healthy Palace Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : Beijing Ji Shui Tan Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : Beijing Shijingshan Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : Beijing Yanhua Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : Fu Xing Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : General Hospital of Second Artillery PLA
Acarbose Cardiovascular Evaluation Trial
Beijing : Peking Union Medical College Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : PLA General Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : Aerospace Central Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : Affiliated to The Capital University of Medical Sciences Beijing Friendship Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : Beijing Anzhen Hospital of The Capital University of Medical Sciences
Acarbose Cardiovascular Evaluation Trial
Beijing : Beijing Pinggu Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : Beijing Yangfangdian Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : China Meitan General Hospita
Acarbose Cardiovascular Evaluation Trial
Beijing : China-Japan Friendship Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : Peking University People's Hospital
Acarbose Cardiovascular Evaluation Trial
Beijing : For Recruiting Locations in
Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina
Changchun : China-Japan Union Hospital of Jilin University
Acarbose Cardiovascular Evaluation Trial
Changchun : The Second Hospital of Jilin University
Acarbose Cardiovascular Evaluation Trial
Changsha : Hunan Provincial People's Hospital
Acarbose Cardiovascular Evaluation Trial
Changsha : Xiangya Hospital Central-South University
Acarbose Cardiovascular Evaluation Trial
Changsha : The Fourth Hospital of Changsha
Acarbose Cardiovascular Evaluation Trial
Changsha : The Third Hospital of Changsha
Acarbose Cardiovascular Evaluation Trial
Chengdu : Huaxi Hospital of Sichuan University
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Chengdu : Chengdu First People's Hospital
Acarbose Cardiovascular Evaluation Trial
Chengdu : Chengdu Second People's Hospital
Acarbose Cardiovascular Evaluation Trial
Chengdu : Sichuan Provincial People's Hospital
Acarbose Cardiovascular Evaluation Trial
Chengdu : The West China Hospital
Acarbose Cardiovascular Evaluation Trial
Chongqing : Chongqing Zhongshan Hospital
Acarbose Cardiovascular Evaluation Trial
Chongqing : Chongqing Medical University Second Afflicated Hospital
Acarbose Cardiovascular Evaluation Trial
Chongqing : Chongqing Third People's Hospital
Acarbose Cardiovascular Evaluation Trial
Chongqing : Da Ping Hospital
Acarbose Cardiovascular Evaluation Trial
Chongqing : The Second People's Hospital of Chongqing
Acarbose Cardiovascular Evaluation Trial
Da Qing : Da Qing Oilfield General Hospital
Acarbose Cardiovascular Evaluation Trial
Dalian : Dalian Central Hospital
Acarbose Cardiovascular Evaluation Trial
Dalian : The First Hospital of Dalian Medical University
Acarbose Cardiovascular Evaluation Trial
Daqing : Daqing General Oil Field Hospital
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Fuzhou : Fujian Provincial Hospital
Acarbose Cardiovascular Evaluation Trial
Fuzhou : The People's Hospital of Fujian Province
Acarbose Cardiovascular Evaluation Trial
Guangzhou : Guangdong Cardiovascular Institute of Guangdong Provincial Hospital
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Guangzhou : Guangdong Nanfang Hospital
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Guangzhou : Guangdong General Hospital
Acarbose Cardiovascular Evaluation Trial
Guangzhou : The First Affiliated Hospital of jinan University
Acarbose Cardiovascular Evaluation Trial
Guangzhou : The Third Affiliated Hospital of Guangzhou Medical College
Acarbose Cardiovascular Evaluation Trial
Guangzhou : The First Affiliated Hospital of Guangdong Pharmaceutical University
Acarbose Cardiovascular Evaluation Trial
Guangzhou : The First Affiliated Hospital of Sun Yat-Sen University
Acarbose Cardiovascular Evaluation Trial
Guangzhou : The Second Affiliated Hospital of Zhongshan University
Acarbose Cardiovascular Evaluation Trial
Guiyang : The Affiliated Hospital of Guiyang Medical College
Acarbose Cardiovascular Evaluation Trial
Hangzhou : Zhe Jiang Hospital
Acarbose Cardiovascular Evaluation Trial
Hangzhou : Sir Run Run Shaw Hospital Affiliated With School of Medicine,Zhe Jiang University
Acarbose Cardiovascular Evaluation Trial
Harbin : The 2nd Affiliated Hospital of Harbin Medical University
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Harbin : The Fourth Affiliated Hospital of Harbin Medical University
Acarbose Cardiovascular Evaluation Trial
Hohhot : Inner Mongolia Hospita
Acarbose Cardiovascular Evaluation Trial
Hong Kong : Queen Mary Hospital
ABSORB EXTEND Clinical Investigation
Hongkong : Prince of Wales Hospital
Acarbose Cardiovascular Evaluation Trial
Jinan : The Central Hospital of Jinan
Acarbose Cardiovascular Evaluation Trial
Jinan : The First People's Hospital of Jinan
Acarbose Cardiovascular Evaluation Trial
Jinan : The General Hospital of Jinan Military Region
Acarbose Cardiovascular Evaluation Trial
Kunming : The First Affiliated Hospital of Kunming Medical College
Acarbose Cardiovascular Evaluation Trial
Kunming : The First People's Hospital of Yunnan Province
Acarbose Cardiovascular Evaluation Trial
Kunming : The Second Affiliated Hospital of Kunming Medical College
Acarbose Cardiovascular Evaluation Trial
Linyi : Linyi People's Hospital
Acarbose Cardiovascular Evaluation Trial
Liuzhou : Liuzhou People's Hospital
Acarbose Cardiovascular Evaluation Trial
Luoyang : The First Affiliated Hospital of Henan Science & Technology University
Acarbose Cardiovascular Evaluation Trial
Nanchang : The Third Affiliated Hospital of Nanchang University
Acarbose Cardiovascular Evaluation Trial
Nanchang : Jiangxi Provincial People's Hospital
Acarbose Cardiovascular Evaluation Trial
Nanchang : The Second Affiliated Hospital of Nanchang University
Acarbose Cardiovascular Evaluation Trial
Nanjing : Nanjing First Hospital
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
NanJing : 81st Hospital of Chinese PLA
Acarbose Cardiovascular Evaluation Trial
Nanjing : BENQ Hospital
Acarbose Cardiovascular Evaluation Trial
NanJing : Jiangsu Provincial Hospital of TCM
Acarbose Cardiovascular Evaluation Trial
Nanjing : Nanjing First Hospital
Acarbose Cardiovascular Evaluation Trial
Nanjing : Jiangsu Province Hospital
Acarbose Cardiovascular Evaluation Trial
NanJing : Jiangsu Province Official Hospital
Acarbose Cardiovascular Evaluation Trial
Nanjing : Nanjing Drum Tower Hospital
Acarbose Cardiovascular Evaluation Trial
Nanjing : Nanjing Zhongda Hospital
Acarbose Cardiovascular Evaluation Trial
Nanjing, : Nanjing Jiangning Hospital
Acarbose Cardiovascular Evaluation Trial
Nanning : 303 Hospital of People's Liberation Army
Acarbose Cardiovascular Evaluation Trial
Nanning : Minzu Hospital of Guangxi Zhuang Autonomous Region
Acarbose Cardiovascular Evaluation Trial
Nanning : The First Affiliated Hospital of Guangxi Medical University
Acarbose Cardiovascular Evaluation Trial
Qingdao : The Qingdao Municiple Hospital
Acarbose Cardiovascular Evaluation Trial
Shanghai : Shanghai 6th People's Hospital, Jiaotong University
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Shanghai : Shanghai Chest Hospital of Jiaotong University
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Shanghai : Changhai Hospital
Acarbose Cardiovascular Evaluation Trial
Shanghai : Shanghai Central Hospital of Yangpu District
Acarbose Cardiovascular Evaluation Trial
Shanghai : Shanghai East Hospital
Acarbose Cardiovascular Evaluation Trial
Shanghai : Shanghai Huadong Hospital
Acarbose Cardiovascular Evaluation Trial
Shanghai : Shanghai Pudong New District People's Hospital
Acarbose Cardiovascular Evaluation Trial
Shanghai : Shanghai Tenth People's Hospital
Acarbose Cardiovascular Evaluation Trial
Shanghai : Shanghai Zhabei District Shibei Hospital
Acarbose Cardiovascular Evaluation Trial
Shanghai : Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Acarbose Cardiovascular Evaluation Trial
Shanghai : Number 411 Hospital of PLA
Acarbose Cardiovascular Evaluation Trial
Shanghai : Putuo District Center Hospital
Acarbose Cardiovascular Evaluation Trial
Shanghai : Renji Hospital Affilicated to Jiaotong University School of Medicine
Acarbose Cardiovascular Evaluation Trial
Shanghai : Ruijin Hospital Affiliated to the Shanghai Jiaotong University Medical School
Acarbose Cardiovascular Evaluation Trial
Shanghai : Shanghai Central Hospital of Xuhui District
Acarbose Cardiovascular Evaluation Trial
Shanghai : Shanghai Jinshan Hospital
Acarbose Cardiovascular Evaluation Trial
Shanghai : Shanghai Ninth People's Hospital
Acarbose Cardiovascular Evaluation Trial
Shanghai : Shanghai Putuo District People's Hospital
Acarbose Cardiovascular Evaluation Trial
Shanghai : Tongji Hospital of Tongji University
Acarbose Cardiovascular Evaluation Trial
Shanghai : Zhongshan Hospital
Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial
Shen Yang : General Hospital of SY Military Institute
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Shenyang : The Fourth Hospital of China Medical University
Acarbose Cardiovascular Evaluation Trial
Shenyang : Shengjing Hospital of China Medical University
Acarbose Cardiovascular Evaluation Trial
Shenzhen : Peking University Shenzhen Hospital
Acarbose Cardiovascular Evaluation Trial
Shihezi : First Affiliated Hospital of the Medical College
Acarbose Cardiovascular Evaluation Trial
Shijiazhuang : The Second Hospital of Hebei Medical University
Acarbose Cardiovascular Evaluation Trial
Shijiazhuang : Bethune International Peace Hospital
Acarbose Cardiovascular Evaluation Trial
Shijiazhuang : The First Hospital of Hebei Medical University
Acarbose Cardiovascular Evaluation Trial
Suzhou : Suzhou Municipal Hospital
Acarbose Cardiovascular Evaluation Trial
Taian : Taian City Central Hospital
Acarbose Cardiovascular Evaluation Trial
Taiyuan : Shanxi Cardiovascular Hospital
Acarbose Cardiovascular Evaluation Trial
Taiyuan : General Hospital of Tisco
Acarbose Cardiovascular Evaluation Trial
Taiyuan : Taiyuan City Central Hospital
Acarbose Cardiovascular Evaluation Trial
Taiyuan : The Third Engineering Bureau Hospital of Ministry of Railway
Acarbose Cardiovascular Evaluation Trial
Tangshan : Tangshan Workers Hospital
Acarbose Cardiovascular Evaluation Trial
Tangshan : The Affiliated Hospital of North China Coal Medical University
Acarbose Cardiovascular Evaluation Trial
Tangshan : Yu Tian County Hospital
Acarbose Cardiovascular Evaluation Trial
Tianjin : TEDA International Cardiovascular Hospital
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Tianjin : The Fifth Central Hospital of Tianjin
Acarbose Cardiovascular Evaluation Trial
Tianjin : Tianjin Chest Hospital
Acarbose Cardiovascular Evaluation Trial
Tianjin : Tianjin Third Central Hospital
Acarbose Cardiovascular Evaluation Trial
Tianjin : Tianjin Union Medicine Centre
Acarbose Cardiovascular Evaluation Trial
Tianjin : Army Police's Medical College Affiliated Hospital
Acarbose Cardiovascular Evaluation Trial
Tianjin : Dagang Oil-Field General Hospital
Acarbose Cardiovascular Evaluation Trial
Tianjin : The Second Hospital of Tianjin Medical University
Acarbose Cardiovascular Evaluation Trial
Tianjin : Tianjin First Center Hospital
Acarbose Cardiovascular Evaluation Trial
Tianjin : Tianjin Union Hospital
Acarbose Cardiovascular Evaluation Trial
Urumqi : General Hospital of Xinjiang Production and Construction Corps
Acarbose Cardiovascular Evaluation Trial
Urumqi : The First Teaching Hospital of Xinjiang Medical University
Acarbose Cardiovascular Evaluation Trial
Urumqi : The 474th Hospital of PLA
Acarbose Cardiovascular Evaluation Trial
Wuhan : Pu'ai Hospital of Wuhan City
Acarbose Cardiovascular Evaluation Trial
Wuhan : Renmin Hospital of Wuhan Univdrsity
Acarbose Cardiovascular Evaluation Trial
Wuhan : Wuhan Asia Heart Hospital
Acarbose Cardiovascular Evaluation Trial
Wuhan : Zhongnan Hospital of Wuhan University
Acarbose Cardiovascular Evaluation Trial
Wuhan : Union Hospital of Tongji Medical College of Huazhong
Acarbose Cardiovascular Evaluation Trial
Wuhan, : Tongji Hospital of Tongji Medical College of Huazhong
Acarbose Cardiovascular Evaluation Trial
Wuxi : Wuxi No.3 People's Hospital
Acarbose Cardiovascular Evaluation Trial
Wuxi : Wuxi People's Hospital
Acarbose Cardiovascular Evaluation Trial
Wuxi : Wuxi No.2 People's Hospital
Acarbose Cardiovascular Evaluation Trial
Xiamen : The First Hospital of Xiamen
Acarbose Cardiovascular Evaluation Trial
Xiamen : Zhongshan Hospital Xiamen University
Acarbose Cardiovascular Evaluation Trial
Xi'an : Xijing Hospital, Fourth Military Medical University
A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion
Xi'an : Affiliated Hospital of Xi'an Medical college
Acarbose Cardiovascular Evaluation Trial
Xi'an : The First Affiliated Hospital of Xi'an Jiaotong University
Acarbose Cardiovascular Evaluation Trial
Xi'an : Xi'an Central Hospital
Acarbose Cardiovascular Evaluation Trial
Yanan : Yan'an People' Hospital
Acarbose Cardiovascular Evaluation Trial
Yan'an : Affiliated Hospital of Yan'an University
Acarbose Cardiovascular Evaluation Trial
Yinchuan : The People's Hospital of Ningxia Hui Autonomous Region
Acarbose Cardiovascular Evaluation Trial
Yinchuan : Affiliated Hospital of Ningxia Medical University
Acarbose Cardiovascular Evaluation Trial
Yinchuan : The First Hospital of Yinchuan
Acarbose Cardiovascular Evaluation Trial
Yulin : The First Hospital of Yulin
Acarbose Cardiovascular Evaluation Trial
Zhangjiakou : The Third Affiliated Hospital of Hebei North University
Acarbose Cardiovascular Evaluation Trial
Zhanjiang : Zhanjiang First People's Hospital
Acarbose Cardiovascular Evaluation Trial
Zhengzhou : The First Affiliated Hospital of Henan College of TCM
Acarbose Cardiovascular Evaluation Trial
Zhengzhou : The People's Hospital of Zhengzhou
Acarbose Cardiovascular Evaluation Trial
ZhengZhou : The Second Affiliated Hospital of Zhengzhou University
Acarbose Cardiovascular Evaluation Trial
Zhongshan : Zhong Shan City People's Hospital
Acarbose Cardiovascular Evaluation Trial
Zhuhai : The Fifth Affiliated Hospital of Sun Yat-Sen University
Acarbose Cardiovascular Evaluation Trial
Czech Republic
Ceske Budejovice :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Chrudim :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Hradec Kralove :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Jihlava :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Jindrichuv Hradec :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
View More »
Prague : General University Hospital
GLP-1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Diabetic Patients With Aortocoronary Bypass
Praha :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Praha 10 : University Hospital Kralovske Vinohrady
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Semily :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Teplice :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Zlin :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Znojmo :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Denmark
Århus N : Århus University Hospital
ABSORB EXTEND Clinical Investigation
Skejby : Aarhus University Hospital
The Nordic-Baltic Bifurcation Study IV
Finland
Helsinki : Helsinki University
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Pori : Satakunta Central Hospital
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT
Turku : Turku PET Centre
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Turku : Turku University Hospital
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
France
Annecy : Centre Hospitalier de la Région Annecienne
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Bordeaux : CHU Bordeaux Haut Lévèque
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
Bron : Hôpital Cardiovasculaire et Pneumologique Louis Pradel
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Caen : Centre Hospitalier Universitaire de Caen - Pôle Anesthésie-Réanimation-SAMU, Avenue de la Côte de Nacre
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
Clermont Ferrand : CHU Clermont Ferrand
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
View More »
Colmar : Hôpital Albert Schweitzer
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Corbeil Essonnes : Centre Hospitalier Sud Francilien
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Dijon : CHU Dijon
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
Haguenau : Centre Hospitalier d'Haguenau
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Lille : CHRU, Hôpital Cardiologique, Département Anesthésie-Réanimation, Bld du Président Jules Leclerc
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
Lyon : Centre Hospitalier Saint Joseph et Saint Luc
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Marseille : CHU Nord
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
Massy : Institut Jacques Cartier (ICPS)
ABSORB EXTEND Clinical Investigation
Massy : Hôpital Privé Jacques Cartier
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Montpellier : Hôpital Arnaud de Villeneuve
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Nîmes : Centre Hospitalier Universitaire Caremeau
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Paris : Chu Pitie Salpetriere
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
Paris : Hopital Saint Joseph
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
Paris : Groupe Hospitalier Pitié Salpêtrière
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Paris : Centre Hospitalo-Universitaire Pitié-Salpetrière
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Pessac : Hospitaux du Haut Leveque
The OMEGA Clinical Trial
Poitiers : CHU Poitiers, Service Anesthésie-Réanimation, 2 rue de Milétrie, BP577
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
Pontoise : Centre Hospitalier Rene Dubos
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Rennes : CHU Rennes
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
Rennes : Hôpital Pontchaillou
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Roissy : Guerbet
Xenetix 350: Comparative Assessment of Image Quality for Coronary CT Angiography
Strasbourg : Nouvel Hopital Civil
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
Strasbourg : Hôpitaux Universitaires de Strasbourg - Nouvel Hôpital Civil
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Toulouse : Clinique Pasteur
ABSORB EXTEND Clinical Investigation
Toulouse : Hopital De Rangueil - CHU
ABSORB EXTEND Clinical Investigation
Toulouse : Centre Hôpital Universitaire Rangueil
The OMEGA Clinical Trial
Toulouse : Centre Hospitalier de Rangueil
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Toulouse Cedex 3 : Clinique Pasteur
The OMEGA Clinical Trial
Villeneuve Saint Georges : CHI de Villeneuve
Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment
Georgia
Tbilisi : Clinic "Guli"
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Tbilisi : Tbilisi State Medical University Alexandre Aladashvili University Clinic
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Tbilisi : Emergency Cardiology Center by Academician G. Chapidze LTD
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Germany
Aachen :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Aachen : University Hospital Aachen
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Bad : Kerckhoff Heart and Thoraxcenter
The OMEGA Clinical Trial
Bad Oeynhausen : Herz- und Diabeteszentrum Nordrhein Westfalen
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
Bad Segeberg : Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH
The OMEGA Clinical Trial
View More »
Berlin : Charité Berlin Campus Steglitz
ABSORB EXTEND Clinical Investigation
Berlin : Charite Humboldt University
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
Berlin : Deutsches Herzzentrum Berlin
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
Bernau : Herzzentrum Brandenburg in Bernau
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Bremen : Klinikum Links der Weser - Senator-Wessling-Str. 1
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Coburg : Klinikum Coburg GmbH
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Essen : Elisabeth-Krankenhaus Essen GmbH
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Hamburg : Medical Care Center Prof. Mathey, Prof. Schofer GmbH
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Hamburg : University Clinica Eppendorf
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Hannover : Medical School Hannover
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
Heidelberg : Uni.Klinikum Heidelberg
ABSORB EXTEND Clinical Investigation
Heidelberg : Abt. Herzchirugie, Universitätsklinikum Heidelberg
Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery
Heidelberg : Universitaetsklinikum Heidelberg
The OMEGA Clinical Trial
Jena : Klinikum der Friedrich Schiller University
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Kiel : Universitätsklinikum Schleswig-Holstein
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Kiel : University Hospital of Kiel
The eSVS® Mesh Randomized Post-Market Study
Kiel : Universitätsklinikum Schleswig-Holstein
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Koeln :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Leipzig : Herzzentrum Universität Leipzig
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
Lubeck : UniversitatsKlinikum Schleswig-Holstein
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Rostock : University of Rostock
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
Ulm : Universitätsklinikum Ulm
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Hungary
Budapest :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Budapest :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Debrecen : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Pécs :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Szeged :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
India
Israel
Ashkelon : Barzilai Medical Center
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Ashkelon : Barzilai Medical Center, Cardiology Dept.
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Beer Sheva : Soroka Medical Center
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Haifa : Cardiovascular department, Carmel medical center
Monitoring and Characterization of Coronary Flow By Transthoracic Parametric Doppler (TPD) During Exercise Stress Test
Haifa : Rambam Health Care Campus
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
View More »
Haifa : Bnei Zion Medical Center
Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graft
Jerusalem : Cardiology Department, Shaarey Zedek Hospital
Assessment of HyperQ Signal for Detecting Ischemia During Dobutamine Stress ECG
Jerusalem : Shaare Zedek Medical Center
Diagnostic Benefits of HyperQTM vs. Conventional ECG Stress Test. Comparison of HyperQ vs. Stress ECG in Women Before Angiography
Kfar Saba : Dr. Silber Clinic
The Diagnostic Benefits of the HyperQTM System in ECG Stress Testing
Natanya : Laniado Hospital
The Israeli MGuard Registry
Petah Tikva : Rabin Medical Center
ABSORB EXTEND Clinical Investigation
Rehovot : Kaplan Medical Center
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Rehovot : Kaplan Medical Center
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Safed : Ziv Medical Center
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Tel viv : Theravitae Co.
ACPs Combined With CABG in Patients With CHF
Zrifin : Asaf Harofe Medical Center
The Israeli MGuard Registry
Italy
Asti : Cardinal Massaia Hospital
COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent
Catanzaro : Catanzaro University Hospital
ABSORB EXTEND Clinical Investigation
Cotignola : Maria Cecilia Hospital
COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent
Milano : Centro Cardiologico Monzino
ABSORB EXTEND Clinical Investigation
Japan
Kobe : Kobe University
Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion
Minato-ku, Tokyo : Non-profit organization Associations for Establishiment of Evidence in Interventions
Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients
Morioka : Iwate Medical University
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
Nishinomiya : Hyogo Medical University
Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion
Tokyo : Keio University
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
View More »
Toyohashi : Toyohashi Heart Center
Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion
TSU : Mie University
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
Yokohama : Saiseikai Yokohama Eastern Hospital
Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion
Yukuhashi : New Yukuhashi hospital
Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion
Korea, Republic of
Chunahn : Dankook University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Daegu : Daegu Catholic University Medical Center
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Daegu : Dong-A University Medical Center
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Daejeon : Chungnam National University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Dongjak-Gu : Boramae Medical Center
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
View More »
GangNeung : GangNeung Asan Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Gwangju : Chonnam National University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Incheon : Inha University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Jeonju : Chonbuk National University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Jinju : Gyeongsang National University Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Jongno-gu : Seoul National University Hospital
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
Seogu : Dong-A Medical Center
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
Seongnam : Bundang CHA Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Seongnam-si : Seoul National University Bundang Hospital
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
Seoul : Asan Medical Center
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Seoul : Hanyang National University Medical Center
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Seoul : Gangnam Severance Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Seoul : Asan Medical Center
Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)
Seoul : Samsung Medical Center
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
Seoul : 8 Locations
LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)
Seoul : Cardiovascular center, Seoul St. Mary's hospital
The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)
Wonju : Wonju Christian Hospital
Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After BioMatrix Stent Implantation
Latvia
Malaysia
Kuala Lumpur : Institute Jantung Negara
ABSORB EXTEND Clinical Investigation
Kuching : Sarawak General Hospital
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Mexico
Aguascalientes : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Celaya : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Chihuahua : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Guadalajara : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
San Luis Potosí : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
View More »
San Luís Potosí : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
San Luis Potosi S.l.p. : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Netherlands
Alkmaar : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Amsterdam :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Amsterdam : Onze Lieve Vrouwe Gasthuis Ziekenhuis
DELIVER Study: DELiverability of the Resolute Integrity Stent in All-Comer Vessels and Cross-OvER Stenting
Amsterdam :
Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
Amsterdam : Academisch Medisch Centrum
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT
View More »
Apeldoorn : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Arnhem :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Beverwijk :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Breda :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Breda : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Delft : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Den Haag : Haga Ziekenhuis locatie Leyweg
The OMEGA Clinical Trial
Den Helder :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Eindhoven :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Eindhoven : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Eindhoven : Catharina ZH Eindhoven
ABSORB EXTEND Clinical Investigation
Eindhoven :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Eindhoven :
Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
Eindhoven : Catharina Ziekenhuis
The OMEGA Clinical Trial
Gouda :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Gouda : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Heerlen :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Heerlen : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Nieuwegein :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Nieuwegein :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Nieuwegein : St Antonius Hospital
Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions
Nijmegen :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Rotterdam :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Rotterdam : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Rotterdam : Erasmus Medical Center
ABSORB EXTEND Clinical Investigation
Rotterdam : Maasstad Ziekenhuis
ABSORB EXTEND Clinical Investigation
Rotterdam :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Rotterdam : Thorax Center - Erasmus MC
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Sneek :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Zwolle :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Zwolle :
Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
New Zealand
Auckland : Mercy Angiography Unit
ABSORB EXTEND Clinical Investigation
Christchurch :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Christchurch : Christchurch Hospital
ABSORB EXTEND Clinical Investigation
Poland
Gdynia : NZOZ Sródmiescie Sp z o.o.
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Katowice :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Katowice : Upper Silesian Heart Center
Treatment of Coronary Artery Disease (CAD) With Bare Metal Stent (BMS) Followed by Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Eluting Stent
Krakow : University Hospital Krakow
ABSORB EXTEND Clinical Investigation
Krakow :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
View More »
Kraków : NZOZ Revita Poradnia Kardiologiczna
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Kraków : Specjalistyczna Praktyka Lekarska Leszek Bryniarski
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Lodz : Updated
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Lódz : MULTI-MED PLUS Sp. z o.o.
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Puławy : KO-MED Marek Konieczny
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Skierniewice : Niepubliczny Zakład Opieki Zdrowotnej Przychodnia Zdrowia "Zadębie"
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Warszawa :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Warszawa : Instytut Kardiologii
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Puerto Rico
Romania
Russian Federation
Barnaul : Altay Regional Cardiologycal Dispensary
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Chita : "Chita State Medical Academy" Curative-Diagnostic Clinic department
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Ekaterinburg : Sverdlovsky Regional Clinical Hospital of Wars Veterans
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Kemerovo : Non-state Institution of healthcare "Department hospital on station Kemerovo of OAO "Russian Railway"
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Kirovsk : Medical centre "Delis", LLC
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
View More »
Moscow :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Moscow : Municipal Hospital #15
Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease
Moscow : Moscow State University of Medicine and Dentistry based on Moscow City Clinical Hospital #71
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Moscow : State healthcare institution of Moscow "City Clinical hospital#15 named after O.M.Filatov"
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Moscow : State Healthcare institution of Moscow"Cardiology Dispensary #2"
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Moscow : First Moscow State Medical University I.M. Sechenov
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Novosibirsk : State Novosibirsk Regional Clinical Hospital
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Pushkin : City Hospital #38 named after Semashko N.A
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Ryazan : State Healthcare Institution "Ryazan regional clinical cardiological dispensary"
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Saint Petersburg :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
St. Petersburg : "Medical Research Institute", LLC
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
St. Petersburg : State Healthcare institution "Municipal Out-patient Clinic #109"
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Tomsk :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Yaroslavl : Municipal Institution of Healthcare "Clinical Hospital #8 of Yaroslavl"
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Singapore
Singapore : National University Hospital
ABSORB EXTEND Clinical Investigation
Singapore : National Heart Center
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
Singapore : National Heart Centre Singapore
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
South Africa
Cape Town :
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Spain
Badalona :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Barcelona :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Barcelona : Hospital Clinico Y Provincial
The OMEGA Clinical Trial
Cartagena :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Galdakao :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
View More »
Gijón :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Madrid : La Paz
ABSORB EXTEND Clinical Investigation
Madrid : Clinico San Carlos
ABSORB EXTEND Clinical Investigation
Madrid :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Malaga :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Santander :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Santiago de Compostela :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Vigo :
ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Vigo Pontevedra : Hospital do Meixoeiro
ABSORB EXTEND Clinical Investigation
Switzerland
Basel : University Hospital
The eSVS® Mesh Post-Marketing Trial
Bern : Inselspital Bern, Kardiologie
ABSORB EXTEND Clinical Investigation
Bern : Department of Cardiology, Bern University Hospital
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
Zurich : Unversitats Spital Zurich
Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
United Kingdom
Cambridge : Addenbrooke's Hospital Updated
TomVasc - Vascular Effects of Tomato Extract
Edinburgh :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Glasgow :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Leicester : Glenfield Hospital
ABSORB EXTEND Clinical Investigation
London :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
View More »
London : King's College Hospital
ABSORB EXTEND Clinical Investigation
London : King's College
MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease
London : University College Hospital London NHS Foundation Trust
Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison
London : King's College Hospital
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT
London : Royal Brompton Hospital
Vein External Support Trial
Middlesex : Harefield Hospital
Vein External Support Trial
Oxford : The John Radcliffe Hospital
Vein External Support Trial
Stoke on Trent :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Swansea :
A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
United States
Washington : Washington Hospital Center
Evaluation of the CardioSond Electronic Stethoscope in the Detection of Coronary Artery Disease
Washington : MedStar Research Institute (Washington Hospital Center)
PRE-DETERMINE Cohort Study
Washington : Washington Hospital Center
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
